isofuranodiene has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, DH; Sun, XY; Yuan, CS; Zhang, H; Zhao, F; Zheng, YP | 1 |
| Conceição, EL; Fung, KP; Gao, JL; Hu, G; Lao, SC; Lee, SM; Li, SP; Wangl, YT; Xiao, Y; Yang, FQ | 1 |
2 other study(ies) available for isofuranodiene and Liver Neoplasms
| Article | Year |
|---|---|
Potential anti-cancer activities of Furanodiene, a Sesquiterpene from Curcuma wenyujin.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Division; Curcuma; Drugs, Chinese Herbal; Female; Fibrosarcoma; Furans; HeLa Cells; Heterocyclic Compounds, 2-Ring; HL-60 Cells; Humans; K562 Cells; Leukemia; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred Strains; Organ Size; Sesquiterpenes; Spleen; Thymus Gland; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2009 |
Furanodiene induces G2/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Division; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Furans; G2 Phase; Heterocyclic Compounds, 2-Ring; Humans; Liver Neoplasms; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; p38 Mitogen-Activated Protein Kinases | 2007 |